Arkema (AKE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
8 Sep, 2026Strategic vision and transformation
Focus on becoming a specialty materials leader with innovative, sustainable solutions for evolving customer needs.
Over 20 years, transformed portfolio to 85% specialty materials and expanded global presence, with €9.1bn sales in 2025.
Five key growth markets: green energy, advanced electronics, sustainable goods, efficient buildings, and health.
Major projects in bio-based materials, batteries, electronics, and solar energy are progressing, with significant CAPEX and EBITDA contributions.
Execution of large projects in Singapore, US, and China to expand capacity in high-demand segments.
Financial performance and shareholder returns
EBITDA margin improved from 6.2% in 2005 to 13.8% in 2025, with EBITDA reaching €1,251m.
Dividend per share grew at 5% annually (2021–2025), reaching €3.60 for 2025, representing 70% of FCF.
Share price outperformed peers and CAC 40, with a 123% increase since 2006.
Net debt stable YoY at €3.6bn (2.9x LTM EBITDA) at end-June 2026, supported by diversified financing and solid credit ratings.
Operational discipline and cost management
Maintains strict cost discipline, with capex below €600m in 2026 and ongoing headcount reduction.
Working capital ratio at 15.8% of annualized sales, with robust cash flow and stable net debt.
Yield and energy efficiency programs in place to offset fixed cost inflation.
Latest events from Arkema
- EBITDA rose 7.4% to €391M, with margin at 16.1%, led by Adhesives, Coatings, and innovation.AKE
Q2 2026 - Resilient 2025 results, strategic investments, and strong governance marked the AGM.AKE
AGM 2026 - Stable volumes and Specialty growth offset lower sales; 2026 EBITDA growth targeted.AKE
Q1 2026 - EBITDA reached €1,251m with strong cash flow and resilience in key growth markets.AKE
Q4 2025 - Ambitious growth, innovation, and sustainability drive strong specialty materials performance.AKE
BNPP Exane CEO Conference Presentation - Q3 2024 EBITDA rose 5.4% to €407 million, margin at 17.0%, amid weak demand and tight debt control.AKE
Q3 2024 - Q2 2024 EBITDA rose 8.2% on 3.8% sales growth; guidance raised to €1.53–1.63bn.AKE
Q2 2024 - Sales rose 1.7% with resilient specialty materials, but profits fell; H2 improvement expected.AKE
Q1 2025 - 2024 EBITDA rose 2.1% to €1.53bn, with Specialty Materials and Asia driving growth.AKE
Q4 2024